Pharmaceuticals, Biotechnology and Life Sciences
SAN DIEGO, Feb. 02, 2023 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today posted a supplement to its…
Appointment of new directors bring diversity, balance and relevant industry expertise to Vaxxinity Establishment of Frontier Exploration Laboratories (“VaxxLabs”) in…
Study in healthy volunteers shows single dose of afamelanotide reduces erythema caused by ultraviolet radiationMELBOURNE, Australia, Feb. 02, 2023 (GLOBE…
NEW YORK and SAN DIEGO, Feb. 01, 2023 (GLOBE NEWSWIRE) — Zentalis™ Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company focused…
HIGH POINT, N.C., Feb. 01, 2023 (GLOBE NEWSWIRE) — vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused…
TORONTO and CHICAGO, Feb. 01, 2023 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals (Medexus) (TSX: MDP) (OTCQX: MEDXF) wishes to inform investors that the…
HOUSTON, Jan. 31, 2023 (GLOBE NEWSWIRE) — In a release issued earlier today by Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), please note…
Validation of Remestemcel-L Potency Assay used in the Phase 3 Trial which Measures In-Vivo Activity based on Mechanism of Action…
TORONTO and CHICAGO, Jan. 31, 2023 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals (Medexus) (TSX: MDP) (OTCQX: MEDXF) plans to host a conference call…
VANCOUVER, BRITISH COLUMBIA, CHATHAM, ONTARIO and TEL-AVIV, ISRAEL, Jan. 31, 2023 (GLOBE NEWSWIRE) — Atlas Global Brands Inc. (“Atlas Global”…